Exilis Pharma Private Limited

Exilis Pharma Private Limited - pharma in Mumbai, Maharashtra, India. Directors, charges & compliance details.
CIN U52100MH2022PTC396439 Incorporated 30 December 2022 ROC Mumbai HQ Mumbai, Maharashtra, India
Active Private Limited Company pharma
Data last updated
Authorised capital
₹1 Lakh
Registered with MCA
Paid-up capital
₹1 Lakh
Issued & subscribed
Company age
4 yrs
Est. 2022
Directors on board
2
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2025
Balance sheet date
Last AGM
30 Sep 2025
Annual general meeting
Company status
Active
MCA master data

About Exilis Pharma Private Limited

Data last updated:

Exilis Pharma Private Limited is a private limited company based in Mumbai, Maharashtra, India. It operates in the pharmaceutical retail and distribution segment of the pharmaceuticals sector. It was incorporated on 30 December 2022.

The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U52100MH2022PTC396439. Its GSTIN is 23AAHCE4009P1ZJ (Madhya Pradesh).

The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Rajesh Kumar Baranwal and Avesh Kumar Jain.

Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at 104 Floor 1 Bussa Industrial Estate Shankarrao Naram Marg Nrpeninsula Copark, Mumbai, Maharashtra, India – 400013.

Company Details of Exilis Pharma Private Limited
CIN U52100MH2022PTC396439
Registration Number 396439
Incorporation Date 30 December 2022
ROC Mumbai
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
Contact Details
  • Email
    Locked
  • Telephone
    Locked
  • Website
    Locked
  • Social Media
    Locked
  • Registered Address
    104 Floor 1 Bussa Industrial Estate Shankarrao Naram Marg Nrpeninsula Copark, Mumbai, Maharashtra, India – 400013
  • Industry
    Pharma, Pharmaceutical Retailers & Distributors
Comprehensive company report
Exilis Pharma Private Limited - one report that includes everything
  • Company details, directors and signatories
  • Historical financials and ratios
  • Shareholding pattern and group structure
  • Charges with holder and property details
  • Legal cases, compliance and MCA filings
  • One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included

Unlock the full report on Exilis Pharma

Financials, compliance, directors, charges, ownership and filings for Exilis Pharma Private Limited in one report.

Financials from FY 2023 Directors & ownership Charges & compliance

Financials of Exilis Pharma Private Limited

FY 2025 filings available

Financial Statement Summary

MetricsFY 2024-25FY 2022-23 to FY 2023-24in the company report
Profit and Loss Statement
Revenue from Operations••••
Other Income••••
Total Revenue••••
Cost of Materials Consumed••••
Employee Benefit Expense••••
Finance Costs••••
Depreciation and Amortisation••••
Other Expenses••••
Total Expenses••••
EBITDA••••
Profit Before Tax••••
Tax Expense••••
Net Profit (PAT)••••
Balance Sheet
Share Capital••••
Reserves and Surplus••••
Net Worth (Total Equity)••••
Long-term Borrowings••••
Short-term Borrowings••••
Trade Payables••••
Total Liabilities••••
Fixed Assets••••
Investments••••
Inventories••••
Trade Receivables••••
Cash and Bank Balance••••
Total Assets••••

Financial Ratios

MetricsFY 2024-25FY 2022-23 to FY 2023-24in the company report
Profitability
EBITDA Margin••••
Net Profit Margin••••
Return on Equity (ROE)••••
Return on Capital Employed (ROCE)••••
Return on Assets (ROA)••••
Liquidity and Debt
Current Ratio••••
Quick Ratio••••
Debt-to-Equity Ratio••••
Interest Coverage Ratio••••
Efficiency and Growth
Asset Turnover••••
Receivable Days••••
Payable Days••••
Inventory Days••••
Revenue Growth••••
Net Profit Growth••••

Paid data: the figures shown as dots, and every line for FY 2022-23 to FY 2023-24, are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Exilis Pharma are in the company report.

Premium access

Financial statements from FY 2023

Earlier years and trend charts are in the company report.

  • Income statements
  • Balance sheets
  • Cash-flow statements
  • Ratios and benchmarks

Board of Directors of Exilis Pharma Private Limited

Exilis Pharma has 2 directors on record. No former directors are listed.

Current Directors

Charges & Borrowings

Exilis Pharma Private Limited does not have any charges (loans) registered with the Registrar of Companies.

Employees and EPFO Compliance

Employment history and EPFO contributions of people linked to Exilis Pharma.

Employee and EPFO history: available in the company report

Recent Activity

Exilis Pharma Private Limited has 2 board changes on record since 2022: 2 appointments. The latest: Avesh Kumar Jain was appointed as Director on 30 Dec 2022.

AGM
Exilis Pharma Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Exilis Pharma Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Mumbai I.
Appointed
Avesh Kumar Jain was appointed as Director.
Appointed
Rajesh Kumar Baranwal was appointed as Director.
Incorporation
30 Dec 2022
Exilis Pharma Private Limited was registered on 30 Dec 2022 with Roc Mumbai I & aged 3 years 9 months as per MCA records.

Credit Ratings, Litigation & Regulatory Alerts

Credit ratings, litigation, and regulatory alerts: available in the company report

MSME Payment Delays

MSME payment history: available in the company report

Subsidiaries & Group Companies

Corporate group structure: available in the company report

GST Compliance

Exilis Pharma has 1 GST registration: 1 active.

Total GSTINs
1
Active
1
GSTINStateStatusRegistered on
23AAHCE4009P1ZJMadhya PradeshActive29 May 2024

GST registrations and filing compliance: available in the company report

MCA Filings & Documents

MCA filings and documents: available in the company report

Frequently Asked Questions

Exilis Pharma is an active private limited company based in Mumbai, Maharashtra, India. The company works in pharmaceutical retailers and distributors, within the pharma industry. It was incorporated on 30 December 2022 (4+ years old) and is registered under CIN U52100MH2022PTC396439.

Exilis Pharma has 2 current directors:

The latest financial statements of Exilis Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 30 September 2025. Year-wise statements from FY 2023 are in the company report.

The GSTIN of Exilis Pharma is 23AAHCE4009P1ZJ, registered in Madhya Pradesh.

The CIN (Corporate Identification Number) of Exilis Pharma is U52100MH2022PTC396439. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.

Exilis Pharma was incorporated on 30 December 2022, making it 4+ years old. It is registered with the Registrar of Companies, Mumbai.

Avesh Kumar Jain was appointed as Director on 30 Dec 2022. Rajesh Kumar Baranwal was appointed as Director on 30 Dec 2022.

The registered office of Exilis Pharma is at 104 Floor 1 Bussa Industrial Estate Shankarrao Naram Marg Nrpeninsula Copark, Mumbai, Maharashtra, India – 400013.

Exilis Pharma operates in the pharma industry, in the pharmaceutical retailers and distributors segment.

Exilis Pharma can be reached at its registered office: 104 Floor 1 Bussa Industrial Estate Shankarrao Naram Marg Nrpeninsula Copark, Mumbai, Maharashtra, India – 400013.

7M+ Indian companies. One platform.

Financials, directors, compliance, charges and shareholding - compiled from official filings and updated regularly.

Subscription plans available